ClinicalTrials.Veeva

Menu

Assessment of Potential Interactions Between Cocaine and RPR 102681 - 1

National Institutes of Health (NIH) logo

National Institutes of Health (NIH)

Status and phase

Completed
Phase 1

Conditions

Cocaine-Related Disorders

Treatments

Drug: Cocaine-Related Disorders

Study type

Interventional

Funder types

NIH

Identifiers

NCT00067535
NIDA-CPU-0003-1

Details and patient eligibility

About

The purpose of this study is to assess Potential Interactions Between iv Cocaine and RPR 102681

Full description

Phase I, Double-Blind, Placebo-Controlled Dose Escalating Assessment of Potential Interactions Between Intravenous Cocaine and RPR 102681

Enrollment

16 patients

Sex

All

Ages

18 to 45 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Includes but is not limited to:

  • Non-treatment seekers
  • DSM-IV criteria for cocaine abuse or dependence
  • Ability to verbalize understanding of consent form and provide written informed consent and verbalize willingness to complete study procedures; be able to comply with protocol requirements

Exclusion criteria

Please contact site for more information.

Trial design

Primary purpose

Diagnostic

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems